Johnson & Johnson (JNJ) Long-Term Deferred Tax (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Long-Term Deferred Tax came in at $6.7 billion in Q1 2026, down 20.78% year-on-year from $8.5 billion in Q1 2025, and down 2.14% quarter-over-quarter from $6.9 billion in Q4 2025.

Johnson & Johnson (JNJ) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Long-Term Deferred Tax across 18 years of filings, most recently posting $6.7 billion for Q1 2026.

  • Long-Term Deferred Tax for Q1 2026 came in at $6.7 billion, down 20.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 billion (down 20.78% YoY), and the FY2025 annual result was $6.9 billion, down 34.29% from the prior year.
  • Long-Term Deferred Tax came in at $6.7 billion for Q1 2026 at Johnson & Johnson, down from $6.9 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 billion in Q4 2024 to a low of $6.7 billion in Q3 2025.
  • The 5-year median for Long-Term Deferred Tax is $9.1 billion (2023), against an average of $8.8 billion.
  • Across the five-year window, Long-Term Deferred Tax grew 19.79% in 2022 and tumbled 34.29% in 2025, its largest moves.
  • Johnson & Johnson's Long-Term Deferred Tax stood at $9.4 billion in 2022, then decreased by 1.2% to $9.3 billion in 2023, then increased by 12.74% to $10.5 billion in 2024, then sank by 34.29% to $6.9 billion in 2025, then fell by 2.14% to $6.7 billion in 2026.
  • The last three Long-Term Deferred Tax figures came in at $6.7 billion (Q1 2026), $6.9 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 6.73 Bn
Dec 28, 2025 6.87 Bn
Sep 28, 2025 6.67 Bn
Jun 29, 2025 6.80 Bn
Mar 30, 2025 8.49 Bn
Dec 29, 2024 10.46 Bn
Sep 29, 2024 9.35 Bn
Jun 30, 2024 9.00 Bn
Mar 31, 2024 10.31 Bn
Dec 31, 2023 9.28 Bn
Oct 1, 2023 9.26 Bn
Jul 2, 2023 8.78 Bn
Apr 2, 2023 8.82 Bn
Jan 1, 2023 8.95 Bn
Oct 2, 2022 9.39 Bn
Jul 3, 2022 9.51 Bn
Apr 3, 2022 9.94 Bn
Jan 2, 2022 10.22 Bn
Oct 3, 2021 10.65 Bn
Jul 4, 2021 10.80 Bn